PeptidePicker
CognitiveResearch

Semax

Also known as: ACTH fragment

A neuro-stimulatory heptapeptide derived from ACTH, rigorously validated as a nootropic. Enhances focus, accelerates problem-solving, and provides neuroprotection against oxidative damage.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2–3 minutes

Typical Dose

300–600 mcg

Administration

Intranasal

Mechanism of Action

Modulates BDNF, NGF, and dopaminergic pathways in the prefrontal cortex, enhancing synaptic plasticity and neuronal survival under stress.

Key Research Areas

nootropicfocusBDNFneuroprotectioncognitive

Frequently Asked Questions

What is Semax?
A neuro-stimulatory heptapeptide derived from ACTH, rigorously validated as a nootropic. Enhances focus, accelerates problem-solving, and provides neuroprotection against oxidative damage.
How does Semax work?
Modulates BDNF, NGF, and dopaminergic pathways in the prefrontal cortex, enhancing synaptic plasticity and neuronal survival under stress.
What is the recommended dosage for Semax?
The typical research dosage is 300–600 mcg, administered via Intranasal. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Semax?
The half-life of Semax is approximately ~2–3 minutes. This affects dosing frequency and timing in research protocols.
Is Semax FDA approved?
Semax is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Semax is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Cognitive